Both were doing the work and keeping too little of it. So we built two solutions—transparent 340B administration and practical automation—around what each of them actually needed.
Dollars were disappearing into complexity.
Hours were disappearing into keying.
A small community clinic was losing 340B value to opaque fees, weak compliance, and a program that ignored how its team actually operated. Dollars intended for care were disappearing into complexity.
Their margin wasn’t being lost to one bad contract—it was going to labor. Technicians spent their shifts keying orders no patient ever saw, and every additional prescription added payroll the pharmacy couldn’t keep adding to.
We made the economics visible, rebuilt the compliance foundation, and created a referral capture process that recovered eligible prescriptions written beyond the clinic’s walls.
We built order-entry automation that worked inside the pharmacy system they already ran—no integration project, no new software for staff to learn. Routine e-scripts, faxes, and refills were entered automatically, and anything unclear was routed to a person instead of guessed at.
The clinic kept more of what it earned and reinvested those resources in patient care. That result became more than a success story—it became the standard for how OptimSync works.
The queue kept moving without new headcount, the labor cost behind each prescription fell, and the pharmacy returned to stable financial footing—staying open, and staying independent, for the community that depends on it.
Where the two stories meet
A clinic taught us where the dollars go. A pharmacy taught us where the hours go.
Both asked for the same thing in the end: keep what you earn, and spend it on the people you serve.
What both beginnings taught us
Affordable medication and the freedom to choose where care and prescriptions come from.
More dollars kept for care and more freedom to make decisions around what patients need.
Fair relationships and practical automation that help local pharmacies remain viable.
The story continues